| Q31031447 | A double-blind randomized phase I clinical trial targeting ALVAC-HIV vaccine to human dendritic cells |
| Q47992091 | A recombinant Bacille Calmette-Guérin construct expressing the Plasmodium falciparum circumsporozoite protein enhances dendritic cell activation and primes for circumsporozoite-specific memory cells in BALB/c mice |
| Q30403003 | Accelerating tuberculosis vaccine trials with diagnostic and prognostic biomarkers |
| Q36727982 | Activities of Murine Peripheral Blood Lymphocytes Provide Immune Correlates That Predict Francisella tularensis Vaccine Efficacy |
| Q52597636 | Adjuvant-Associated Peripheral Blood mRNA Profiles and Kinetics Induced by the Adjuvanted Recombinant Protein Candidate Tuberculosis Vaccine M72/AS01 in Bacillus Calmette-Guérin-Vaccinated Adults. |
| Q37372321 | Adjuvant-induced Human Monocyte Secretome Profiles Reveal Adjuvant- and Age-specific Protein Signatures |
| Q52609661 | Advances in HIV-1 Vaccine Development. |
| Q34458640 | Associations between DNA methylation and schizophrenia-related intermediate phenotypes - a gene set enrichment analysis |
| Q35789759 | Big-data-based edge biomarkers: study on dynamical drug sensitivity and resistance in individuals. |
| Q35923822 | Biological challenges to effective vaccines in the developing world |
| Q40979359 | Blood Interferon Signatures Putatively Link Lack of Protection Conferred by the RTS,S Recombinant Malaria Vaccine to an Antigen-specific IgE Response |
| Q44168441 | Characterization of T-cell immune responses in clinical trials of the candidate RTS,S malaria vaccine |
| Q38111212 | Characterizing vaccine responses using host genomic and transcriptomic analysis. |
| Q38599514 | Clinical development of RTS,S/AS malaria vaccine: a systematic review of clinical Phase I-III trials |
| Q38456515 | Complex correlates of protection after vaccination |
| Q44168331 | Controlled Human Malaria Infection: Applications, Advances and Challenges. |
| Q35964579 | Early Transcriptome Signatures from Immunized Mouse Dendritic Cells Predict Late Vaccine-Induced T-Cell Responses |
| Q38962848 | Gene-expression analysis for prediction of RTS,S-induced protection in humans |
| Q64939319 | Identification of potential biomarkers of vaccine inflammation in mice. |
| Q37108439 | Immunity to viruses: learning from successful human vaccines |
| Q89777595 | Innate transcriptional effects by adjuvants on the magnitude, quality, and durability of HIV envelope responses in NHPs |
| Q38169040 | Key roles of adjuvants in modern vaccines |
| Q38413749 | Molecular signatures for vaccine development. |
| Q37625332 | Molecular signatures of antibody responses derived from a systems biology study of five human vaccines |
| Q38739590 | Predicting RTS,S Vaccine-Mediated Protection from Transcriptomes in a Malaria-Challenge Clinical Trial |
| Q26800494 | Profiling the host response to malaria vaccination and malaria challenge |
| Q90147842 | Selection of adjuvants for vaccines targeting specific pathogens |
| Q34855189 | Sequential waves of gene expression in patients with clinically defined dengue illnesses reveal subtle disease phases and predict disease severity |
| Q26782580 | Systems Biology Approach for Cancer Vaccine Development and Evaluation |
| Q38807837 | Systems Vaccinology: Applications, Trends, and Perspectives |
| Q40334346 | Systems analysis of protective immune responses to RTS,S malaria vaccination in humans |
| Q38535385 | Systems integration of innate and adaptive immunity |
| Q47104983 | Systems serology: profiling vaccine induced humoral immunity against HIV. |
| Q34402910 | Systems vaccinology |
| Q36090112 | Systems vaccinology: Enabling rational vaccine design with systems biological approaches |
| Q35784377 | Systems vaccinology: learning to compute the behavior of vaccine induced immunity |
| Q27690799 | Systems vaccinology: probing humanity's diverse immune systems with vaccines |
| Q33855179 | Systems-level analysis of innate immunity |
| Q36215165 | T-cell exhaustion, co-stimulation and clinical outcome in autoimmunity and infection. |
| Q38608064 | Tensor decomposition-based unsupervised feature extraction applied to matrix products for multi-view data processing. |
| Q27314524 | The Combined Deficiency of Immunoproteasome Subunits Affects Both the Magnitude and Quality of Pathogen- and Genetic Vaccination-Induced CD8+ T Cell Responses to the Human Protozoan Parasite Trypanosoma cruzi |
| Q98160149 | The Current Status of Enteric Fever Diagnostics and Implications for Disease Control |
| Q28285472 | The RTS,S malaria vaccine |
| Q36092323 | Transcriptional changes induced by candidate malaria vaccines and correlation with protection against malaria in a human challenge model |
| Q36050652 | Transcriptional profiling of vaccine-induced immune responses in humans and non-human primates |
| Q46157489 | Transcriptional profiling technology for studying vaccine responses: an untapped goldmine |
| Q55106515 | Transcriptomic Studies of Malaria: a Paradigm for Investigation of Systemic Host-Pathogen Interactions |
| Q47400686 | Transcriptomics in Human Challenge Models |
| Q30922949 | Type I interferon related genes are common genes on the early stage after vaccination by meta-analysis of microarray data |
| Q62658190 | Using 'collective omics data' for biomedical research training |
| Q26799374 | Utilizing population variation, vaccination, and systems biology to study human immunology |
| Q35923851 | Vaccinology in the era of high-throughput biology |
| Q55381231 | Whole blood transcriptome changes following controlled human malaria infection in malaria pre-exposed volunteers correlate with parasite prepatent period. |
| Q46660168 | Will Systems Biology Deliver Its Promise and Contribute to the Development of New or Improved Vaccines? From Data to Understanding through Systems Biology |
| Q47781510 | Will Systems Biology Deliver Its Promise and Contribute to the Development of New or Improved Vaccines? Systems Biology Views of Vaccine Innate and Adaptive Immunity |